Literature DB >> 8082565

Genetic control of hepatocarcinogenesis in C3H mice.

N R Drinkwater1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8082565     DOI： 10.3109/03602539409029791

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  4 in total

1.  Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.

Authors:  T M Poole; N R Drinkwater
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.

Authors:  L M Sargent; X Zhou; C L Keck; N D Sanderson; D B Zimonjic; N C Popescu; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

3.  Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.

Authors:  Drazen B Zimonjic; Veronika Ullmannova-Benson; Valentina M Factor; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Cancer Genet Cytogenet       Date:  2009-05

4.  Dose-dependent incidence of hepatic tumors in adult mice following perinatal exposure to bisphenol A.

Authors:  Caren Weinhouse; Olivia S Anderson; Ingrid L Bergin; David J Vandenbergh; Joseph P Gyekis; Marc A Dingman; Jingyun Yang; Dana C Dolinoy
Journal:  Environ Health Perspect       Date:  2014-02-03       Impact factor: 9.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.